Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Nov 2, 2026
- Incorporated
- Delaware
- Filings on record
- 58 filings
- On EDGAR
- CIK 2042347
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 3
News 4
Prospectuses and Registrations 4
Ownership 8 of 39
- 4 Insider reported a trade Nov 4, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 5, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 5, 2026
- 4 Insider reported a trade Jun 24, 2026
- SCHEDULE 13D Large holder reported an active stake May 11, 2026
- SCHEDULE 13G Large holder reported a passive stake May 11, 2026
- 3 Insider reported their initial holding May 6, 2026
Other 8
- EFFECT Notice that a registration became effective Apr 30, 2026
- S-1MEF Apr 30, 2026
- CERT Exchange certified a listing Apr 30, 2026
- 8-A12B Registration of a security for exchange listing Apr 28, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Feb 27, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jan 29, 2026
- DRS Draft registration statement, submitted confidentially Nov 21, 2025
- D Oct 31, 2024
Everything here comes from Seaport Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.